Chad

Chad

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
12.39 (9.89 - 14.46) 2019 Modelled IHME
13.23 (10.46 - 15.58) 2018 Modelled IHME
13.63 (10.51 - 16.50) 2017 Modelled IHME
13.63 (10.37 - 16.19) 2016 Modelled IHME
13.63 (10.07 - 16.29) 2015 Modelled IHME
13.8 (10.23 - 16.43) 2014 Modelled IHME
14.15 (10.65 - 16.72) 2013 Modelled IHME
14.58 (11.06 - 17.27) 2012 Modelled IHME
14.98 (11.58 - 17.83) 2011 Modelled IHME
15.28 (11.78 - 18.31) 2010 Modelled IHME
15.48 (12.10 - 18.35) 2009 Modelled IHME
15.66 (12.37 - 18.46) 2008 Modelled IHME
15.82 (12.58 - 18.64) 2007 Modelled IHME
15.96 (12.77 - 18.83) 2006 Modelled IHME
16.07 (12.82 - 19.11) 2005 Modelled IHME
16.16 (12.79 - 19.10) 2004 Modelled IHME
16.23 (12.82 - 19.10) 2003 Modelled IHME
16.3 (12.91 - 19.19) 2002 Modelled IHME
16.38 (12.87 - 19.47) 2001 Modelled IHME
16.46 (12.91 - 19.72) 2000 Modelled IHME
16.59 (13 - 19.77) 1999 Modelled IHME
16.76 (12.99 - 19.85) 1998 Modelled IHME
16.94 (13.01 - 20.07) 1997 Modelled IHME
17.07 (12.91 - 20.31) 1996 Modelled IHME
17.12 (12.83 - 20.54) 1995 Modelled IHME
17.11 (12.95 - 20.32) 1994 Modelled IHME
17.05 (13.02 - 20.10) 1993 Modelled IHME
16.95 (13.11 - 20) 1992 Modelled IHME
16.8 (13.14 - 19.93) 1991 Modelled IHME
16.6 (13.15 - 19.81) 1990 Modelled IHME
4.87 (0.48 - 36.43) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
7.88 (5.66 - 10.01) 2019 Modelled IHME
8.56 (6.05 - 10.79) 2018 Modelled IHME
8.88 (6.01 - 11.66) 2017 Modelled IHME
8.83 (5.89 - 11.29) 2016 Modelled IHME
8.78 (5.58 - 11.23) 2015 Modelled IHME
8.87 (5.66 - 11.24) 2014 Modelled IHME
9.08 (5.85 - 11.51) 2013 Modelled IHME
9.37 (6.16 - 11.95) 2012 Modelled IHME
9.73 (6.56 - 12.52) 2011 Modelled IHME
10.13 (6.99 - 13.29) 2010 Modelled IHME
10.81 (7.52 - 13.95) 2009 Modelled IHME
11.85 (8.29 - 15.03) 2008 Modelled IHME
12.97 (9.12 - 16.43) 2007 Modelled IHME
13.9 (9.84 - 17.71) 2006 Modelled IHME
14.35 (10.17 - 18.42) 2005 Modelled IHME
14.46 (10.32 - 18.22) 2004 Modelled IHME
14.54 (10.58 - 18.31) 2003 Modelled IHME
14.6 (10.65 - 18.22) 2002 Modelled IHME
14.65 (10.64 - 18.24) 2001 Modelled IHME
14.72 (10.63 - 18.38) 2000 Modelled IHME
14.84 (10.66 - 18.46) 1999 Modelled IHME
15.02 (10.51 - 18.83) 1998 Modelled IHME
15.2 (10.34 - 19.12) 1997 Modelled IHME
15.35 (10.11 - 19.47) 1996 Modelled IHME
15.41 (9.96 - 19.80) 1995 Modelled IHME
15.39 (10.11 - 19.74) 1994 Modelled IHME
15.31 (10.08 - 19.51) 1993 Modelled IHME
15.19 (10.12 - 19.49) 1992 Modelled IHME
15.02 (10.20 - 19.53) 1991 Modelled IHME
14.8 (10.20 - 19.53) 1990 Modelled IHME
3.08 (0.29 - 26.20) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
51 (42 - 60) 2019 Modelled IHME
52 (43 - 61) 2018 Modelled IHME
52 (43 - 61) 2017 Modelled IHME
52 (43 - 61) 2016 Modelled IHME
52 (43 - 61) 2015 Modelled IHME
52 (43 - 61) 2014 Modelled IHME
52 (43 - 61) 2013 Modelled IHME
52 (43 - 61) 2012 Modelled IHME
52 (43 - 61) 2011 Modelled IHME
52 (43 - 61) 2010 Modelled IHME
52 (43 - 61) 2009 Modelled IHME
52 (43 - 61) 2008 Modelled IHME
52 (44 - 61) 2007 Modelled IHME
52 (44 - 61) 2006 Modelled IHME
52 (43 - 61) 2005 Modelled IHME
52 (43 - 61) 2004 Modelled IHME
52 (43 - 61) 2003 Modelled IHME
52 (43 - 61) 2002 Modelled IHME
52 (43 - 62) 2001 Modelled IHME
52 (43 - 61) 2000 Modelled IHME
52 (43 - 62) 1999 Modelled IHME
52 (43 - 61) 1998 Modelled IHME
52 (43 - 61) 1997 Modelled IHME
52 (43 - 61) 1996 Modelled IHME
52 (43 - 61) 1995 Modelled IHME
51 (42 - 61) 1994 Modelled IHME
51 (43 - 61) 1993 Modelled IHME
51 (42 - 61) 1992 Modelled IHME
51 (42 - 61) 1991 Modelled IHME
51 (42 - 61) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
41 2018 Survey/reported WHO/UNICEF
41 2017 Survey/reported WHO/UNICEF
41 2016 Survey/reported WHO/UNICEF
42 2015 Survey/reported WHO/UNICEF
36 2014 Survey/reported WHO/UNICEF
39 2013 Survey/reported WHO/UNICEF
40 2012 Survey/reported WHO/UNICEF
33 2011 Survey/reported WHO/UNICEF
39 2010 Survey/reported WHO/UNICEF
24 2009 Survey/reported WHO/UNICEF
17 2008 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
3.37 (2.69 - 4.26) 2019 Modelled IHME
3.34 (2.65 - 4.22) 2018 Modelled IHME
3.31 (2.61 - 4.20) 2017 Modelled IHME
3.27 (2.61 - 4.13) 2016 Modelled IHME
3.24 (2.56 - 4.11) 2015 Modelled IHME
3.24 (2.57 - 4.09) 2014 Modelled IHME
3.24 (2.57 - 4.08) 2013 Modelled IHME
3.24 (2.59 - 4.07) 2012 Modelled IHME
3.24 (2.58 - 4.08) 2011 Modelled IHME
3.24 (2.57 - 4.08) 2010 Modelled IHME
3.24 (2.58 - 4.08) 2009 Modelled IHME
3.24 (2.58 - 4.06) 2008 Modelled IHME
3.23 (2.58 - 4.06) 2007 Modelled IHME
3.23 (2.57 - 4.05) 2006 Modelled IHME
3.22 (2.56 - 4.06) 2005 Modelled IHME
3.2 (2.57 - 4.02) 2004 Modelled IHME
3.17 (2.55 - 3.98) 2003 Modelled IHME
3.14 (2.52 - 3.95) 2002 Modelled IHME
3.11 (2.50 - 3.92) 2001 Modelled IHME
3.1 (2.49 - 3.90) 2000 Modelled IHME
3.1 (2.49 - 3.90) 1999 Modelled IHME
3.12 (2.51 - 3.90) 1998 Modelled IHME
3.14 (2.52 - 3.93) 1997 Modelled IHME
3.16 (2.52 - 3.97) 1996 Modelled IHME
3.18 (2.54 - 3.97) 1995 Modelled IHME
3.19 (2.56 - 3.97) 1994 Modelled IHME
3.21 (2.58 - 3.98) 1993 Modelled IHME
3.22 (2.60 - 3.99) 1992 Modelled IHME
3.23 (2.60 - 4.01) 1991 Modelled IHME
3.24 (2.61 - 4.01) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
18 (12 - 24) 2019 Modelled IHME
17 (12 - 24) 2018 Modelled IHME
17 (12 - 24) 2017 Modelled IHME
17 (12 - 24) 2016 Modelled IHME
18 (12 - 24) 2015 Modelled IHME
18 (12 - 24) 2014 Modelled IHME
18 (12 - 25) 2013 Modelled IHME
18 (12 - 25) 2012 Modelled IHME
18 (12 - 24) 2011 Modelled IHME
18 (12 - 25) 2010 Modelled IHME
18 (12 - 25) 2009 Modelled IHME
18 (12 - 25) 2008 Modelled IHME
18 (12 - 25) 2007 Modelled IHME
18 (12 - 25) 2006 Modelled IHME
18 (12 - 25) 2005 Modelled IHME
18 (12 - 25) 2004 Modelled IHME
18 (12 - 25) 2003 Modelled IHME
18 (12 - 25) 2002 Modelled IHME
18 (12 - 25) 2001 Modelled IHME
19 (12 - 26) 2000 Modelled IHME
19 (12 - 25) 1999 Modelled IHME
19 (12 - 26) 1998 Modelled IHME
19 (12 - 25) 1997 Modelled IHME
19 (12 - 26) 1996 Modelled IHME
19 (13 - 26) 1995 Modelled IHME
19 (13 - 26) 1994 Modelled IHME
19 (13 - 26) 1993 Modelled IHME
19 (13 - 27) 1992 Modelled IHME
20 (13 - 27) 1991 Modelled IHME
20 (13 - 27) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
300 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
12.39 (%)
2019
(9.89 - 14.46(%))
IHME
HCV (RNA/cAg+)
3.37 (%)
2019
(2.69 - 4.26(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
1,793
2019
(1,303 - 2,388)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
241
2019
(164 - 335)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
7.88 (%)
2019, latest modelled
(5.66 - 10.01(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines